A Study of LY3532226 in Healthy Participants

NCT04923269 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3532226
DRUG: Placebo

Sponsor

Eli Lilly and Company